DOCSLIB.ORG

Policy and Public Engagement for Rabies Elimination in Africa

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Afrique one African Science Partnership for Intervention Research aspire news Excellence (Afrique One-ASPIRE)/Newsletter N°4, June 2020 Policy and Public Engagement for Rabies Elimination in Africa . News Questions to In this issue Blockchain technology for the Prof Sarah Cleaveland, DVM, PhD, fight against rabies University of Glasgow Portrait Dossier Distribution of TTP Rabies Policy engagement for fellows and various Rabies elimination in Africa research subjects (East and West) www.afriqueoneaspire.net - Newsletter June 2020 | 1 - Summary Editorial : ….…………………………………………………………………….…………………………………………….........……………………………………... 3 Rabies, a silent killer in the noisy killer COVID-19 pandemic! News : ..………………………………………………….……………………………………………...…………………………………………….………………………….. 4 Block Rabies Workshop Learning Package (Bouaké and Abidjan) Portrait : ............……………………………………………………...……………………………………………………………………….............................. 4-5 Afrique One-ASPIRE rabies team members Dossier: ..……………………………………………………...……….…………………………….………………………………………………………………….. 6-10 Dr Prisca N’Dour (Integrated regional approaches for Rabies elimination in East and West Africa). Christian Duamor, Kennedy Lushashi and Ahmed Lugelo share Tanzania experience in community engagement and collaboration with government. Nestor N'Dri, Rose Delima A. N'Guessan, Vessaly Kallo and Bassirou Bonfoh (Mass dog vaccination campaign and actors training). Jean Mbaipago Nodjimbadem, Séraphin Madjadinan Alladoumngar, community engagement and integrated case management in Tchad. Questions to Sarah Cleaveland : ………………………………………………...……………………………….……........11 Projects News : ………………………………………………..…………………………………………....…………………………………………....12-13 MOMIB project Meningitis elimination Wound Management Publication Director Contributors Prof Bassirou Bonfoh Prof Bassirou Bonfoh 01 P.O Box 1303 Abidjan 01 Editor-in-chief Prof Sarah Cleaveland Fax: (+225) 23 45 12 11 Lisette Anoh-Affanou Dr des. Kathrin Heitz-Tokpa Tel: (+225) 23 47 27 90 / 92 Dr Andrée Prisca N’dour Co-editor Dr Kallo Vessaly [email protected] Dr Kathrin Heitz-Tokpa Ahmed Lugelo Christian Tetteh Duamor Copy editor Kennedy Lushasi ©Afrique One-ASPIRE/2020 Dr Katharina Kreppel Rose Delima Akissi N’guessan Nestor Kouassi N’Dri Graphic Designer Nodjimbadem M’bapaïgo Jean Afrique One-ASPIRE Séraphin Madjadinan Alladoumngar - 2 | www.afriqueoneaspire.net - Newsletter June 2020 Editorial Rabies, a silent killer in the noisy killer COVID-19 pandemic! abies continues to plague the world and throughout Africa, even if today the pandemic of the century, COVID-19 presents itself as more worrying in health, social and economic perspectives. In this COVID-19 pandemic, one should not overlook the Rother endemic infections, zoonosis and pathologies as they may go neglected and lead to more effect on the population. According to the World Health Organization (WHO), 60'000 rabies deaths worldwide are registered each year. More than 95% of these human cases of rabies occur in Africa and Asia, especially in children. Rabies is transmitted to humans by animals, with over 99% of cases due to dog bites. Africa currently registers 2'080 deaths each month, far beyond the current COVID-19 data in Africa. Highlighting these figures along-side the growing COVID-19 pandemic is justified for various reasons, including (i) failure of health systems, (ii) lack of access to care, (iii) Prof Bassirou Bonfoh inadequate supply chains and (iv) lack of communication Director of Afrique One-ASPIRE between sectors. Both diseases emerged at different periods Photo credit ©Afrique One-ASPIRE at the human, animal and environment interface and the knowledge on rabies can feed the COVID-19 strategies. Several measures are being taken to achieve zero human implemented? What are the policy adoptions? How did deaths by 2030 by stepping up the responses. Among them, they reverse the progression of rabies? Which countries the One Health approach, the emergence of a collaborative have benefited from it? How are intersectoral and political approach between different health sectors, including collaboration done? And who are the actors on the ground? human and animal health, for an integrated control system. We provide in this newsletter answers to these questions. Finally, thanks to EDCTP, we are launching, the Blockchain Afrique One-ASPIRE strategies include policy and community high coverage rabies post-exposure prophylaxis this April, to ownership of the control interventions based on developed achieve zero human rabies deaths in Africa. It is the first time scientific solutions in Africa. How are these strategies the Blockchain technology is used in health systems in Africa. Prof Bassirou Bonfoh intervention with Blockchain technology for the fight again rabies - CSRS (Côte d’Ivoire) Photo credit ©Afrique One-ASPIRE www.afriqueoneaspire.net - Newsletter June 2020 | 3 - News Blockchain technology for the fight against rabies Blockchain technology workshop for the fight again rabies - CSRS (Côte d’Ivoire) Photo credit ©Afrique One-ASPIRE lockRabies is the short form of “Blockchain high coverage rabies monitoring of the vaccine stocks in the countries covered by the project. post-exposure prophylaxis to achieve zero human rabies deaths in Mali and Côte d’Ivoire are the two pilot countries of the study. They both Africa”. This EDCTP-funded project is the latest associated project benefited from post-bite vaccination protocols (post-exposure prophylaxis) Bof Afrique One-ASPIRE in the fight to eliminate rabies by 2030. With in a project funded by the Global Alliance for Vaccine and Immunization the use of blockchain technology, it strives to address poor communication (GAVI) between 2016 and 2018. Furthermore, the GAVI project led to the between public and animal health services and remedy delays in the supply establishment of a thorough database of the rabies burden in these two chain of vaccines. countries, which will serve as a baseline for the new project. The team led by Prof. Jakob Zinsstag, Principal Investigator (PI) of the project BlockRabies is a collaboration between the Swiss Tropical and Public Health and Co-PI of Afrique One-ASPIRE, met at Centre Suisse de Recherches Institute, two institutions in Mali (the Central Veterinary Laboratory and the Scientifiques (CSRS) in Côte d’Ivoire from 6th to 7th January 2020 on the University of Sciences, Techniques and Technologies of Bamako), three invitation of Prof. Bassirou Bonfoh, Director of Afrique One-ASPIRE and Co-PI institutions in Côte d'Ivoire (CSRS, the National Institute of Public Hygiene and of the new project. the Directorate of Veterinary Services), the company Health Information During this preparatory workshop, Afrique One-ASPIRE fellows from the Traceability (HIT) Foundation based in Switzerland and Institute Pasteur in Thematic Training Programme "Rabies", coming from Côte d’Ivoire, Mali, France. Senegal and Tanzania, learnt about how the blockchain technology During the workshop, the objectives of each work package were presented works and how it will serve in rabies control strategies. This non-corruptible and a timeline for the different activities established. The project will last 4 application will allow public and animal health authorities to (i) develop years. After the successful preparatory workshop, the project was officially an electronic database on integrated case management as part of the kick-started in April 2020. care and monitoring system of dog bite victims, and (ii) to ensure better Afrique One-ASPIRE learning package is exported to public university Learning Package group photo Photo credit ©Afrique One-ASPIRE t the request of the management team of the department institutional rules and procedures. In short, the training allowed participants of Communication, Environment and Society of the Bouaké to improve their skills to build a successful research career. They are now University in Abidjan, Côte d’Ivoire, the programme Afrique One- able to design and manage a project technically and financially, make ASPIRE organized the first edition of the “Learning package” at professional oral presentations and posters, as well as use new tips and AAlassane Ouattara University in Bouaké (UAO). tricks in scientific English. At the end of the course, participants proudly showed their certificates. The module-based Learning Package is part of the support for research training that the CSRS offers to universities of Côte d´Ivoire and its sub The Learning Package was delivered with the support of Afrique One- regions. For one week, from January 27th to 31st 2020, 40 researchers ASPIRE to provide young African scientists with these essential tools, and lecturers from the department of Communication, Environment and which are necessary to become internationally competitive. Additionally, Society benefitted from this capacity strengthening programme. Afrique One-ASPIRE and CSRS aim to develop facilitators by providing training for trainers and hence some new facilitators used the delivery of Among other subjects, the training focussed on the management this Learning Package to learn. of research projects, the use of software, communication skills and - 4 | www.afriqueoneaspire.net - Newsletter June 2020 Team Dr Godfrey Mbaruku, PI († 2018), IHI, Prof Bassirou Bonfoh, DVM, PI ad Interim, Dr Nicodemus James Govella, PI, IHI, Tanzania Director of Afrique One-ASPIRE, associated Tanzania researcher at CSRS, Côte d’Ivoire [email protected] [email protected] Dr Walter Ossebi, Co-PI, Dr
Recommended publications
  • Leapfrogging Africa Sustainable Innovation in Health, Education and Agriculture

    Leapfrogging Africa Sustainable Innovation in Health, Education and Agriculture

    Berlin Institute for Population and Development Leapfrogging Africa Sustainable Innovation in Health, Education and Agriculture hen in Rwanda bring in blood reserves +++ sustainable intensification makes farming more productive +++ online teaching not only during the pandemic +++ avoidable infectious diseases +++ kanian solutions +++ top school +++ development reduces the number of children +++ avoiding the mistakes of industrialized countries +++ central development areas: health, education and agriculture +++ Leapfrogging in Africa +++ higher yields +++ Diagnosis out of About the Berlin Institute The Berlin Institute for Population and Development is an independent think tank that deals with issues of regional and global demographic change. The Institute was founded in 2000 as a non-profit foundation and has the task of raising awareness of demographic change, promoting sustainable development, introducing new ideas into politics and developing concepts for solving demographic and development policy problems. In its studies, discussion and background papers, the Berlin Institute prepares scientific information for the political decision-making process. Further information, as well as the possibility to subscribe to the free regular newsletter “Demos”, can be found at www.berlin-institut.org. Support the independent work of the Berlin Institute. The Berlin Institute receives no public institutional support whatsoever. Project funding, research contracts, donations and endowments make the successful work of the Institute possible. The Berlin Institute is recognized as a non-profit organization. Donations and endowments are tax deductible. The Friends of the Berlin Institute brings together interested and committed individuals, companies and foundations who are willing to support the Berlin Institute financially and with ideas. You can find information about the Supporters’ Association at http://www.berlin-institut.org/foerderkreis-des-berlin-instituts.html.
  • TRANSLATING RECOMMENDATIONS INTO ACTION FIRST PROGRESS REPORT on IMPLEMENTATION of RECOMMENDATIONS November 2011–June 2012

    TRANSLATING RECOMMENDATIONS INTO ACTION FIRST PROGRESS REPORT on IMPLEMENTATION of RECOMMENDATIONS November 2011–June 2012

    Commission on information and accountability for Women’s and Children’s Health TRANSLATING RECOMMENDATIONS INTO ACTION FIRST PROGRESS REPORT ON IMPLEMENTATION OF RECOMMENDATIONS November 2011–June 2012 Commission on information and accountability for Women’s and Children’s Health TRANSLATING RECOMMENDATIONS INTO ACTION FIRST PROGRESS REPORT ON IMPLEMENTATION OF RECOMMENDATIONS November 2011–June 2012 This is a preliminary report covering activities that have been carried out since November 2011, when the Strategic Workplan for Accountability (strategic workplan) was endorsed in a stake­ holders’ meeting in Ottawa, co­hosted by the Government of Canada and WHO. Working groups were formed to implement the strategic workplan. The first few months of work focused on institutional accountability processes by establishing national frameworks and global support activities. Results will become more apparent in the course of the upcoming implementation year. This report is prepared to inform the independent Expert Review Group for its progress report to the United Nations Secretary­General. © World Health Organization 2012 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e­mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
  • Tanzania National Institute for Medical Research TANZANIA Leonard Mboera

    Tanzania National Institute for Medical Research TANZANIA Leonard Mboera

    ALIGNMENT AND HARMONISATION IN HEALTH RESEARCH COHRED Council on Health Research for Development Gabriela Montorzi Sylvia de Haan Carel IJsselmuiden Tanzania National Institute for Medical Research TANZANIA Leonard Mboera An assessment of the health research system A country report of the AHA series Council on Health Research for Development (COHRED) ALIGNMENT AND HARMONISATION IN HEALTH RESEARCH COHRED TANZANIA An assessment of the health research system A country report of the AHA series Council on Health Research for Development Gabriela Montorzi Sylvia de Haan Carel IJsselmuiden Tanzania National Institute for Medical Research Leonard Mboera Council on Health Research for Development (COHRED) Acknowledgements We are grateful to all our collaborators for contributing in different ways to the successful completion of this study. Thanks are due to: • NACCAP for providing the financial support for this study. • All stakeholders interviewed, for their availability and valuable contribution to the understanding of the Tanzania Health Research System. • Donor agency headquarters for validating financial data and contributing with financial information. Keywords Alignment and harmonisation, national health research systems, Tanzania, Canada, Denmark, Ireland, The Netherlands, Norway, Sweden, Switzerland, United Kingdom, Paris declaration on aid effectiveness, research financing ISBN 92-9226-034-0 Copyright and Fair Use The Council on Health Research for Development (COHRED) holds the copyright to its publications and web pages but encourages duplication and dissemination of these materials for non-commercial purposes. Proper citation is requested and modification of these materials is prohibited. Permission to make digital or hard copies of part or all of this work for personal or classroom use is granted without fee and without a formal request provided that copies are not made or distributed for profit or commercial purposes and that copies bear this notice and full citation on the first page.
  • Ethical Implications of Malaria Vaccine Development

    Ethical Implications of Malaria Vaccine Development

    Institute of Biomedical Ethics and History of Medicine, University of Zurich Director: Prof. Dr. med. Dr. phil. Nikola Biller-Andorno ______________________________________________________________________ Dissertation under the supervision of Prof. Dr. med. Dr. phil. Nikola Biller-Andorno and Prof. Dr. phil. Marcel Tanner Ethical Implications of Malaria Vaccine Development INAUGURAL-DISSERTATION To receive the title of (Dr. sc. med./PhD) awarded by the Faculty of Medicine University of Zurich submitted by Machteld van den Berg Dissertation committee: Prof. Dr. med. Dr. phil. Nikola Biller-Andorno (chair and main supervisor) Prof. Dr. phil. Marcel Tanner (co-supervisor) PD Dr. med. et sc. nat. Sonja Merten This dissertation has been accepted by the Medical Faculty, University of Zurich upon request of Prof. Dr. Dr. Nikola Biller- Andorno Zurich 2019 Publication record These dissertation chapters have been published/submitted in/to the following journals: 1. RTS,S malaria vaccine pilot studies: addressing the human realities in large-scale clinical trials Machteld van den Berg, Bernhards Ogutu, Nelson Sewankambo, Nikola Biller-Andorno, Marcel Tanner Published: May 2019 Journal: BMC Trials 2. Clinical trials in low-resource settings: the perspectives of caregivers of paediatric participants from Uganda, Tanzania and Kenya Machteld van den Berg, Bernhards Ogutu, Nelson Sewankambo, Sonja Merten, Nikola Biller-Andorno, Marcel Tanner Published: June 2019 Journal: Tropical Medicine & International Health 3. Applying complexity theory to model
  • 5.09 Otras Ciencias Sociales

    5.09 Otras Ciencias Sociales

    CONICYT Ranking por Disciplina > Sub-área OECD (No Académicas) Comisión Nacional de Investigación 5. Ciencias Sociales > 5.9 Otras Ciencias Sociales Científica y Tecnológica PAÍS INSTITUCIÓN RANKING PUNTAJE FRANCE Centre National de la Recherche Scientifique (CNRS) 1 5,000 USA University of Illinois Chicago Hospital 2 5,000 GERMANY Max Planck Society 3 5,000 TAIWAN Academia Sinica - Taiwan 4 5,000 CANADA Centre for Addiction & Mental Health - Canada 5 5,000 USA Centers for Disease Control & Prevention - USA 6 5,000 USA VA Boston Healthcare System 7 5,000 ITALY Consiglio Nazionale delle Ricerche (CNR) 8 5,000 CHINA Chinese Academy of Sciences 9 5,000 SPAIN Consejo Superior de Investigaciones Cientificas (CSIC) 10 5,000 NORWAY Institute of Transport Economics 11 5,000 USA National Bureau of Economic Research 12 5,000 RUSSIA Russian Academy of Sciences 13 5,000 ARGENTINA Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) 14 5,000 CZECH REPUBLIC Czech Academy of Sciences 15 5,000 FRANCE Institut National de la Sante et de la Recherche Medicale (Inserm) 16 5,000 USA Microsoft 17 5,000 USA National Institutes of Health (NIH) - USA 18 5,000 USA Research Triangle Institute 19 5,000 USA Atlanta VA Health Care System 20 5,000 USA US Department of Veteran Affairs 21 5,000 NETHERLANDS Academic Medical Center Amsterdam 22 5,000 USA New York State Psychiatry Institute 23 5,000 GERMANY IZA Institute Labor Economics 24 5,000 GERMANY Helmholtz Association 25 5,000 ROMANIA Romanian Academy of Sciences 26 5,000 UNITED KINGDOM NERC Natural
  • Comparison of Clinical Trials in the Industrialized World and Africa Christian Burri; Swiss Tropical and Public Health Institute

    Comparison of Clinical Trials in the Industrialized World and Africa Christian Burri; Swiss Tropical and Public Health Institute

    Life Science Forum Basel 2010 Comparison of Clinical Trials in the industrialized world and Africa Christian Burri; Swiss Tropical and Public Health Institute Department of Medicines Research Basel, 23rd June 2010 Comparison of Clinical Trials in the industrialized world and Africa Life Science Forum Basel PD Dr. Christian Burri Head of Department Swiss Tropical & Public Health Institute The Swiss TPH … … is an associated institute of the University of Basel … has the mandate to contribute to the improvement of the health of populations internationally and nationally through excellence in research, services, and teaching & training at the levels of innovation, validation & application … has over 500 staff from 40 nations thereof ~100 PhD students 1 Life Science Forum Basel 2010 Comparison of Clinical Trials in the industrialized world and Africa Christian Burri; Swiss Tropical and Public Health Institute Swiss Tropical & Public Health Institute The Swiss TPH … … the Swiss Tropical Institute (STI) was founded in 1943 as a public organisation based on a local government act … became the “Swiss Tropical and Public Health Institute” (Swiss TPH) at the beginning of the year 2010 after the integration of the Institute of Social & Preventive Medicine (ISPM) of the University of Basel … is supported at ~20 % by the Swiss Federal Government & Canton of Basel- Stadt … earns the greater part of funding through competitively acquired project funds and the earnings of the Service Departments Agenda • Contribution by the Swiss Tropical & Public Health
  • Surveillance of Zoonotic Infectious Disease Transmitted by Small Companion Animals

    Surveillance of Zoonotic Infectious Disease Transmitted by Small Companion Animals

    Emerging Infectious Disease journal ISSN: 1080-6059 Volume 18, Number 12—December 2012 Online Report Peer Reviewed Report Available Online Only Surveillance of Zoonotic Infectious Disease Transmitted by Small Companion Animals Michael J. Day (/eid/article/18/12/12-0664_article#comment) , Edward Breitschwerdt, Sarah Cleaveland, On This Page Umesh Karkare, Chand Khanna, Jolle Kirpensteijn, Thijs Kuiken, Michael R. Lappin, Jennifer McQuiston, Elizabeth Mumford, Tanya Myers, Clarisa B. Palatnik-de-Sousa, Carol Rubin, Gregg Takashima, and Alex Companion Animals Thiermann Author affiliations: Author affiliations: University of Bristol, Langford, UK (M.J. Day); North Carolina Zoonotic Infections in State University, Raleigh, North Carolina, USA (E. Breitschwerdt); University of Glasgow, Glasgow, UK (S. Companion Animals Cleaveland); Mumbai, India (U. Karkare); National Cancer Institute, Bethesda, Maryland, USA (C. Human Zoonotic Khanna); Utrecht University, Utrecht, the Netherlands (J. Kirpensteijn); Erasmus Medical Centre, Disease Surveillance Rotterdam, the Netherlands (T. Kuiken); Colorado State University, Fort Collins, Colorado, USA (M.R. Lappin); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. McQuiston, T. Myers, C. Surveillance of Rubin); World Health Organization, Geneva, Switzerland (E. Mumford); Federal University of Rio de Zoonoses in Janeiro, Rio de Janeiro, Brazil (C.B. Palatnik-de-Sousa); Portland, Oregon, USA (G. Takashima); World Production and Wild Organisation for Animal Health, Paris, France (A. Thiermann) Animals Suggested citation for this article Surveillance of Abstract Zoonoses in Small Companion Animals The One Health paradigm for global health recognizes that most new human infectious diseases will Opportunities for emerge from animal reservoirs. Little consideration has been given to the known and potential zoonotic Small Companion infectious diseases of small companion animals.
  • 14Th Annual RBM VCWG Meeting Moevenpick Hotel Route De Pré

    14Th Annual RBM VCWG Meeting Moevenpick Hotel Route De Pré

    14th Annual RBM VCWG Meeting Moevenpick hotel Route de Pré Bois 20, 1215 Geneva, Switzerland 30 January - 1 February 2019 Participants list # Family name First name Name of the employer Country Email 1 Aawi Agnidoufeyi Ministry of Health Togo [email protected] 2 Abdelhamid Elmahdi Muzamil Institute of Endemic Diseases, University of Khartoum Sudan [email protected] 3 Abebe Aklilu Seyoum Abt Associates United States of America [email protected] 4 Abeku Tarekegn Malaria Consortium United Kingdom [email protected] 5 Achee Nicole University of Notre Dame United States of America [email protected] 6 Adey Richard Adey Business Development GmbH Austria [email protected] 7 Agyei Samuel Asiedu Anglogold Ashanti Malaria Control Ltd. Ghana [email protected] 8 Ahmed Ayman University of Khartoum Sudan [email protected] 9 Aidenagbon Godwin Chemonics Nigeria [email protected] 10 Akim Ikupa Swiss Tropical and Public Health Institute Tanzania [email protected] 11 Akogbeto Codjo Martin Ministry of Health Benin [email protected] 12 Ali Abdullah Ministry of Health Tanzania Zanzibar [email protected] 13 Alssada Methaq National Malaria Control Programme Yemen [email protected] 14 Alvarez Ana Unitaid Switzerland [email protected] 15 Ameneshewa Birkinesh World Health Organization Republic of the Congo [email protected] 16 Arruti Errasti Begoña Goizper Group Spain [email protected] 17 Asiedu Samuel Anglogold Ashanti Malaria Control Ltd. Ghana [email protected] 18 Assan Malik Kof Anglogold Ashanti Malaria Control Ltd. Ghana [email protected] 19 Atta-Obeng Christian National Malaria Control Programme Ghana [email protected] 20 Baldini Francesco University of Glasgow United Kingdom [email protected] 21 Barasa Sheila Clinton Health Access Initiative Kenya [email protected] 22 Baud Francis Clariant Plastics & Coatings Ltd.
  • Developing a Stepwise Approach for Rabies Prevention and Control

    Developing a Stepwise Approach for Rabies Prevention and Control

    18 ISSN 1810-0732 FAO ANIMAL PRODUCTION AND HEALTH More than 50 000 people die from rabies worldwide every year. Most of the victims live in developing countries in Africa and Asia, and are exposed to the rabies virus through dog bites. Every case of rabies prevented is a life saved, so there is an urgent need to implement rabies prevention diligently and globally. In November 2012, the Food and Agriculture Organization of the United Nations (FAO) and the Global Alliance for Rabies Control (GARC) convened 21 experts in canine rabies surveillance and prevention at FAO headquarters in Rome, Italy, to develop a new tool to aid health programme planners and managers. Participants included rabies experts from two rabies-endemic countries (Kenya and China), academic institutions, GARC, the World Health Organization (WHO), the World Organisation for Animal Health (OIE) and FAO. Building on successes and lessons learned in the use of the FAO-developed progressive control pathway for Foot-and-Mouth disease, the workshop participants developed the first model for a stepwise approach to rabies prevention and control. The approach comprises six stages, ranging from Stage 0, where no information on proceedings rabies is available in a suspected rabies-endemic area, to Stage 5, where valid and timely epidemiological surveillance data confirm the elimination of rabies in humans and canines. The stepwise approach is intended for adoption and adaptation by national rabies control and elimination programmes as a tool for managing rabies surveillance, control and prevention. DEVELOPING A STEPWISE APPROACH FOR RABIES PREVENTION AND CONTROL FAO/GARC Workshop Rome, Italy 6-8 November 2012 Cover photographs: Left: ©Inangolet Francis Olaki Centre and right: ©FAO/Dian Marteen 18 FAO ANIMAL PRODUCTION AND HEALTH proceedings DEVELOPING A STEPWISE APPROACH FOR RABIES PREVENTION AND CONTROL FAO/GARC Workshop Rome, Italy 6-8 November 2012 FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 2013 Recommended Citation FAO.
  • Alliance for Case Studies for Global Health

    Alliance for Case Studies for Global Health

    Case Studies for Global Health Building relationships. Sharing knowledge. Alliance for Case Studies for Global Health ® www.casestudiesforglobalhealth.org Case Studies for Global Health Building relationships. Sharing knowledge. Case Studies for Global Health Case Studies for Global Health: Building relationships. Sharing knowledge. ISBN #0-9778444-8-X Copyright ©2009 by the Alliance for Case Studies for Global Health The logos of the Bill & Melinda Gates Foundation, International AIDS Vaccine Institute (IAVI), Association of University Technology Managers (AUTM), Global Health Progress and TDR are the trademark of the respective organizations. All rights reserved. This material may be quoted or reproduced without charge for noncommercial purposes only; please acknowledge source. This publication does not imply endorsement by the Alliance for Case Studies for Global Health of any product or service, nor any organization, corporation or institution. Case Studies for Global Health is available in electronic format and limited print copies are available. You may download a copy of the book or individual case studies at: www.casestudiesforglobalhealth.org. All other inquiries: Managing Editor Alliance for Case Studies for Global Health 111 Deer Lake Road, Suite 100 Deerfield, IL 60015 USA Web site: www.casestudiesforglobalhealth.org E-mail: [email protected] Printed in the USA on FSC-certified paper. Methods and Acknowledgement This publication is an initiative of the Alliance for Case Studies We reached out to many universities, organizations, companies for Global Health, a collaboration of the Association of University and governments to identify potential case studies. To capture as Technology Managers (AUTM), the Bill & Melinda Gates many diverse stories as possible, we published a call for case studies Foundation, Global Health Progress, the International AIDS in various newsletters, journals and on Web sites during the fall Vaccine Initiative (IAVI) and Tropical Disease Research (TDR).
  • A Case Study of the Uganda National Minimum Healthcare Package

    A Case Study of the Uganda National Minimum Healthcare Package

    Regional Network for DISCUSSION Equity in Health in east Paper and southern Africa NO. 110110 A case study of the Uganda National Minimum Healthcare Package Dr. Isaac Kadowa Ministry of Health, Uganda In association with Ifakara Health Institute and Training and Research Support Centre In the Regional Network for Equity in Health in east and southern Africa (EQUINET) EQUINET DISCUSSION PAPER 110 The role of Essential Health Benefits in the delivery of integrated services: Learning from practice in East and Southern Africa August 2017 With support from IDRC (Canada) Table of contents Executive summary ............................................................................................................................. 2 1. Background ................................................................................................................................... 4 1.1 Context ............................................................................................................................................................. 4 1.2 Health, morbidity and mortality profile ..................................................................................................... 4 1.3 Organisation of health system ................................................................................................................... 5 2. Methods for the case study: ........................................................................................................... 8 3. Development of the essential health benefit ..............................................................................
  • The Role of Animals in Emerging Viral Diseases

    The Role of Animals in Emerging Viral Diseases

    The Role of Animals in Emerging Viral Diseases Edited by Nicholas Johnson AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an Imprint of Elsevier Academic Press is an imprint of Elsevier 525 B Street, Suite 1900, San Diego, CA 92101-4495, USA 32 Jamestown Road, London NW1 7BY, UK 225 Wyman Street, Waltham, MA 02451, USA Copyright © 2014 Elsevier Inc. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher. Permissions may be sought directly from Elsevier’s Science & Technology Rights, Department in Oxford, UK: phone (+44) (0) 1865 843830; fax (+44) (0) 1865 853333; email: [email protected]. Alternatively, visit the Science and Technology Books website at www.elsevierdirect.com/rights for further information. Notice No responsibility is assumed by the publisher for any injury and/or damage to persons, or property as a matter of products liability, negligence or otherwise, or from any use or, operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. British Library Cataloguing-in-Publication Data A catalog record for this book is available from the British Library. Library of Congress Cataloging-in-Publication Data A catalog record for this book is available from the Library of Congress. ISBN: 978-0-12-405191-1 For information on all Academic Press publications visit our website at elsevierdirect.com Typeset by TNQ Books and Journals www.tnq.co.in Printed and bound in China 14 15 16 17 18 10 9 8 7 6 5 4 3 2 1 Dedication This book is dedicated to Clive and Jean for a lifetime of support Contributors Andrew B.